Bank of America
FBLG icon

Bank of America’s FibroBiologics FBLG Stock Holding History

Bank of America’s Portfolio FBLG Stock Details FBLG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-2,409
Closed -$10.8K – 6966
2025
Q4 		$10.8K Hold
2,409
– – ﹤0.01% 6149
2025
Q3 		$26.3K Buy
2,409
+21
+0.9% +$251 ﹤0.01% 7012
2025
Q2 		$29.7K Sell
2,388
-2,214
-48% -$39.9K ﹤0.01% 6959
2025
Q1 		$82.8K Buy
4,602
+109
+2% +$3.11K ﹤0.01% 6576
2024
Q4 		$180K Sell
4,493
-373
-8% -$20K ﹤0.01% 6166
2024
Q3 		$301K Buy
4,866
+839
+21% +$55.8K ﹤0.01% 5804
2024
Q2 		$402K Buy
+4,027
New +$768K ﹤0.01% 5475

Other funds holding FBLG

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
FEG
Fund Evaluation Group Cincinnati, Ohio $3.7B AUM 16.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CFP
Cascade Financial Partners San Diego, California $1.15B AUM 33.6% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
NA
NewEdge Advisors New Orleans, Louisiana $33.6B AUM 31.03% 1-Year Est. Return
Vanguard Global Advisers
Vanguard Global Advisers Malvern, Pennsylvania $215B AUM

Bank of America's FBLG Position: Q1 2026 in Review

Bank of America sold out of FibroBiologics (FBLG) in Q1 2026, closing a stake of 2,409 shares — an estimated $10.8K sold.

Bank of America first reported a position in FBLG in Q2 2024 and held it in 7 quarters. The position peaked at $402K in Q2 2024. 17 funds tracked by Wall St. Rank hold FBLG as of Q1 2026.

  • Bank of America reported no remaining FibroBiologics position as of Q1 2026 after selling out during the quarter.
  • Bank of America sold 2,409 FibroBiologics shares in Q1 2026, an estimated $10.8K.
  • Bank of America first reported a position in FibroBiologics in Q2 2024 and held it in 7 quarters.
  • Bank of America's FibroBiologics position peaked at $402K in Q2 2024.
  • 17 funds tracked by Wall St. Rank held FibroBiologics as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.